The first and second phase of insulin secretion in naive Chinese type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 59, Issue 6, 2010, Pages 780-786

  Lin, Jiunn Diann ^a   Hsia, Te Lin ^b   Wu, Chung Ze ^c   Su, Ching Chieh ^b   Ma, Wen Ya ^b   Hsieh, An Tsz ^c   Hsieh, Chang Hsun ^d   Wang, Kun ^b   Chu, Yi Min ^b   Pei, Dee ^b  

^a Division of Endocrinology and Metabolism

^b Cardinal Tien Hospital

^c Division of Endocrinology and Metabolism

^d National Defense Medical School

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANALYTIC METHOD; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOCRINE FUNCTION TEST; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; MODIFIED LOW DOSE GRADED GLUCOSE INFUSION TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 77952247297     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.09.024     Document Type: Article

References (40)

1. DeFronzo R.A., Bonadonna R.C., and Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15 (1992) 318-368
2. Kahn S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46 (2003) 3-19
3. U.K. Prospective Diabetes Study Group. UK prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44 (1995) 1249-1258
4. Polonsky K.S., Sturis J., and Bell G.I. Seminars in medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus-a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334 (1996) 777-783
5. Caumo A., and Luzi L. First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 287 (2004) E371-385
6. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
7. Stumvoll M., Mitrakou A., Pimenta W., et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23 (2000) 295-301
8. Bergman R.N. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38 (1989) 1512-1527
9. Gjessing H.J., Damsgaard E.M., Matzen L.E., Froland A., and Faber O.K. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus. Diabetes Care 10 (1987) 558-562
10. Nelson R.L. Oral glucose tolerance test: indications and limitations. Mayo Clin Proc 63 (1988) 263-269
11. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-223
12. Byrne M.M., Sturis J., and Polonsky K.S. Insulin secretion and clearance during low-dose graded glucose infusion. Am J Physiol 268 (1995) E21-27
13. Herman W.H., Fajans S.S., Smith M.J., Polonsky K.S., Bell G.I., and Halter J.B. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene. Diabetes 46 (1997) 1749-1754
14. Yang C.C., Lin J.D., Kuo K.L., et al. The comparison of second phase insulin secretion in patients treated with repaglinide or gliclazide. Diabetes Metab Syndr Clin Res Rev 1 (2007) 37-42
15. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
16. Cerasi E., and Luft R. Plasma-insulin response to sustained hyperglycemia induced by glucose infusion in human subjects. Lancet 2 (1963) 1359-1361
17. Bergman R.N., Phillips L.S., and Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68 (1981) 1456-1467
18. Johnston C., Ward W.K., Beard J.C., McKnight B., and Porte Jr. D. Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetic patients. Diabet Med 7 (1990) 119-125
19. Gulli G., Ferrannini E., Stern M., Haffner S., and DeFronzo R.A. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41 (1992) 1575-1586
20. Pimenta W., Korytkowski M., Mitrakou A., et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 273 (1995) 1855-1861
21. Van Haeften T.W., Dubbeldam S., Zonderland M.L., and Erkelens D.W. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests. Diabetes Care 21 (1998) 278-282
22. Vauhkonen I., Niskanen L., Vanninen E., Kainulainen S., Uusitupa M., and Laakso M. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest 101 (1998) 86-96
23. Weiss R., Caprio S., Trombetta M., Taksali S.E., Tamborlane W.V., and Bonadonna R. Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 54 (2005) 1735-1743
24. Cerasi E., Luft R., and Efendic S. Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study. Diabetes 21 (1972) 224-234
25. Pei D., Hsiao C.F., Hung Y.J., et al. The insulin sensitivity, glucose sensitivity, and acute insulin response to glucose load in adolescent type 2 diabetes in Taiwanese. Diabetes Metab Res Rev 22 (2006) 26-33
26. Park J.Y., Lee K.U., Kim C.H., et al. Past and current obesity in Koreans with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 35 (1997) 49-56
27. Kloppel G., Lohr M., Habich K., Oberholzer M., and Heitz P.U. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4 (1985) 110-125
28. Leahy J.L., Bonner-Weir S., and Weir G.C. Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 81 (1988) 1407-1414
29. Maclean N., and Ogilvie R.F. Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 4 (1955) 367-376
30. Saito K., Yaginuma N., and Takahashi T. Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. Tohoku J Exp Med 129 (1979) 273-283
31. Clark A., Wells C.A., Buley I.D., et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9 (1988) 151-159
32. Huxley R., James W.P., Barzi F., et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 9 Suppl 1 (2008) 53-61
33. Brunzell J.D., Robertson R.P., Lerner R.L., et al. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 42 (1976) 222-229
34. Porte Jr. D., and Kahn S.E. Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?. Diabetes 38 (1989) 1333-1336
35. Temple R.C., Carrington C.A., Luzio S.D., et al. Insulin deficiency in non-insulin-dependent diabetes. Lancet 1 (1989) 293-295
36. Eaton R.P., Allen R.C., and Schade D.S. Hepatic removal of insulin in normal man: dose response to endogenous insulin secretion. J Clin Endocrinol Metab 56 (1983) 1294-1300
37. Toffolo G., Breda E., Cavaghan M.K., Ehrmann D.A., Polonsky K.S., and Cobelli C. Quantitative indexes of beta-cell function during graded up & down glucose infusion from C-peptide minimal models. Am J Physiol Endocrinol Metab 280 (2001) E2-E10
38. Rossetti L., Giaccari A., and DeFronzo R.A. Glucose toxicity. Diabetes Care 13 (1990) 610-630
39. Yki-Jarvinen H. Toxicity of hyperglycaemia in type 2 diabetes. Diabetes Metab Rev 14 Suppl 1 (1998) S45-S50
40. Hsieh C.H., Hung Y.J., He C.T., et al. The capability of glucose toxicity on severe type 2 diabetes. Endocr Res 31 (2005) 149-158